PMB.
Methods | RCT 1989‐1991 | |
Participants | 35 (0*) FIGO stage IIB‐IVA, bulky IB, IIA | |
Interventions | CT + RT vs RT CT: CDDP 60mg/m2 MTX 300 mg/m2 BLM 30 mg. Every 14 days for 3 cycles. RT: External beam 42.5 Gy in 20F over 28 days. Intracavitary 76‐80Gy |
|
Outcomes | Survival Disease‐free survival Loco‐regional disease‐free survival Metastases‐free survival | |
Notes | Treatment comparison 1 | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Allocation concealment (selection bias) | Unclear risk | B ‐ Unclear |